Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.

in t' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MM, Stricker BH.

N Engl J Med. 2001 Nov 22;345(21):1515-21.

3.

[The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].

de Jong D, Jansen RW, Verbeek MM, Kremer HP.

Ned Tijdschr Geneeskd. 2002 Nov 2;146(44):2074-8. Review. Dutch.

PMID:
12448960
4.

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review.

Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN.

Neuroepidemiology. 2004 Jul-Aug;23(4):159-69. Review.

PMID:
15279021
5.

[Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].

Blain H, Jouzeau JY, Blain A, Terlain B, Tréchot P, Touchon J, Netter P, Jeandel C.

Presse Med. 2000 Feb 12;29(5):267-73. Review. French.

PMID:
10701410
6.

Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?

Ho L, Qin W, Stetka BS, Pasinetti GM.

CNS Drugs. 2006;20(2):85-98. Review.

PMID:
16478285
7.

Epidemiology of dementia and Alzheimer's disease.

Hendrie HC.

Am J Geriatr Psychiatry. 1998 Spring;6(2 Suppl 1):S3-18. Review.

PMID:
9581216
8.

Non-cholinergic strategies for treating and preventing Alzheimer's disease.

Doraiswamy PM.

CNS Drugs. 2002;16(12):811-24. Review.

PMID:
12421115
9.

Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis.

Wang J, Tan L, Wang HF, Tan CC, Meng XF, Wang C, Tang SW, Yu JT.

J Alzheimers Dis. 2015;44(2):385-96. doi: 10.3233/JAD-141506. Review.

PMID:
25227314
10.

An update on type 2 diabetes, vascular dementia and Alzheimer's disease.

Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ.

Exp Gerontol. 2012 Nov;47(11):858-64. doi: 10.1016/j.exger.2012.07.014. Epub 2012 Aug 3. Review.

PMID:
22884853
11.

Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials.

Gorelick PB.

Ann N Y Acad Sci. 2010 Oct;1207:155-62. doi: 10.1111/j.1749-6632.2010.05726.x. Review.

PMID:
20955439
12.

Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies.

Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd.

Br J Psychiatry. 2013 May;202(5):329-35. doi: 10.1192/bjp.bp.112.118307. Review.

13.

Can Alzheimer's or vascular dementia be prevented with control of vascular risk factors?

Goldberg TH, Griffith JP.

W V Med J. 2011 May-Jun;107(3):20-5. Review. No abstract available.

PMID:
21702410
14.

Is dementia preventable? Focus on Alzheimer's disease.

Barak Y, Aizenberg D.

Expert Rev Neurother. 2010 Nov;10(11):1689-98. doi: 10.1586/ern.10.159. Review.

PMID:
20977327
15.
16.
17.

Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease.

O'Brien J, Jackson JW, Grodstein F, Blacker D, Weuve J.

Epidemiol Rev. 2014;36:83-103. doi: 10.1093/epirev/mxt008. Epub 2013 Sep 15. Review.

18.

Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.

Qiu C, Kivipelto M, von Strauss E.

Dialogues Clin Neurosci. 2009;11(2):111-28. Review.

19.

Non-psychiatric comorbidity associated with Alzheimer's disease.

Duthie A, Chew D, Soiza RL.

QJM. 2011 Nov;104(11):913-20. doi: 10.1093/qjmed/hcr118. Epub 2011 Jul 18. Review.

20.

[Recent development of non-steroidal anti-inflammatory drugs on the neuro-inflammation of Alzheimer's disease].

Ma XW, Li JZ, Zhang TT, Du GH.

Yao Xue Xue Bao. 2014 Sep;49(9):1211-7. Review. Chinese.

PMID:
25518320
Items per page

Supplemental Content

Write to the Help Desk